Official Department of Labor Disclosure·Form 5500 (2024 Regulatory Return)

ADVANCED MOLECULAR DIAGNOSTICS

EIN:45-•••••••
•
Plan #:000
•
136 SUMMIT AVE, MONTVALE, NJ 07645
Renewal Anniversary
Jan 2027 (Active RFP Window)
Covered Lives
111
Total Plan Assets
$311,852
Avg Balance / Participant
$2,809

Plan Overview & Regulatory Summary

The ADVANCED MOLECULAR DIAGNOSTICS 401(K) PLAN is a corporate employee benefits plan sponsored by ADVANCED MOLECULAR DIAGNOSTICS, headquartered in MONTVALE, NJ. Based on official Department of Labor Form 5500 disclosures on record, the plan provides Pension coverage to company personnel across its operational footprint.

According to regulatory disclosures, the plan administers $311,852 in total fiduciary assets across 111 covered participants—an average balance of $2,809 per participant. Plan governance and fiduciary oversight are administered by corporate leadership at the sponsor's principal offices in MONTVALE, NJ.

The policy operates on an annual renewal anniversary occurring in January. For commercial employee benefits brokers and advisory consultants, the standard pre-renewal evaluation and carrier benchmarking window begins 60 to 90 days prior to January 1, 2027, when corporate benefits committees and CFOs actively evaluate plan performance, carrier fees, and competing proposals.

Plan Specifications & Filing Ledger

Form 5500
Official Plan Name:ADVANCED MOLECULAR DIAGNOSTICS 401(K) PLAN
Benefit Classification:Pension
Filing Type:5500 (2024 Return)
Covered Lives:111 participants
Total Plan Assets:$311,852
Average Account Balance:$2,809 / life
Renewal Anniversary:Jan 2027 (Active RFP Window)

Incumbent Broker & Schedule A Intelligence

Schedule A
Incumbent Brokerage Firm:•••••••••••• (Locked)
Primary Insurance Carrier:•••••••• (Locked)
Schedule A Annual Commissions:$•••,••• (Locked)
Direct Fiduciary Phone:(•••) •••-•••• (Locked)

Plan Administration & Executive Governance

Named Plan Fiduciary / Administrator
Plan Administrator / Benefits Committee
(•••) •••-•••• (Pro Required)
Corporate Headquarters On File
ADVANCED MOLECULAR DIAGNOSTICS
136 SUMMIT AVE, MONTVALE, NJ 07645

Frequently Asked Questions

When does ADVANCED MOLECULAR DIAGNOSTICS's employee benefit plan renew?

ADVANCED MOLECULAR DIAGNOSTICS's ADVANCED MOLECULAR DIAGNOSTICS 401(K) PLAN operates on an annual policy cycle that renews in January (2027). The active RFP and carrier benchmarking window begins 60 to 90 days before the renewal date.

How many participants are covered under ADVANCED MOLECULAR DIAGNOSTICS's benefit plan?

According to the latest federal Form 5500 filing, ADVANCED MOLECULAR DIAGNOSTICS's plan covers 111 participants.

What is the total asset size of ADVANCED MOLECULAR DIAGNOSTICS's retirement plan?

ADVANCED MOLECULAR DIAGNOSTICS's plan holds $311,852 in total plan assets, representing approximately $2,809 per participant.

ErisaDB Pro Access
$149 / mo

Unlock Exact Renewal Date, Broker Fees & Direct Contacts

Get full unblurred access to ADVANCED MOLECULAR DIAGNOSTICS and over 920,000 corporate benefit plans across all 50 states.

  • Exact policy renewal date & 90-day RFP countdown
  • Incumbent broker & advisory agency names
  • Itemized Schedule A commissions & consulting fees
  • Direct named administrator phone & filing contact
  • 2,500 monthly CSV export credits included
Upgrade to Pro ($149/mo)

Instant access • No long-term contract • Cancel anytime

RFP Procurement Timeline
1
60–90 Days Prior:CFO & benefits committee evaluate broker performance & quote market.
2
30 Days Prior:Carrier negotiations lock; open enrollment materials prepared.
3
Anniversary Day (Jan 1):New plan year begins; broker of record locked.